COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 39: Articles 381-390  | Next

Persistent SARS-CoV-2 Spike is Associated with Localized Immune Dysregulation in Long COVID Gut Biopsies
Abraham Soria, S., Peterson, P., VanElzakker, M. B., Tankelevich, M., Mehandru, S., Proal, A., Putrino, D., Freire, M.
10.64898/2026.03.09.707564 — Posted: 2026-03-12
Preliminary stability studies of a ss-SARS-CoV-2 virus-like particle vaccine
Torresi, J., Edeling, M. A., Earnest-Silveira, L., Carrera, J., Yap, A. H. Y., Hans, D.
10.64898/2026.03.11.711036 — Posted: 2026-03-12
Evaluation of pre-Omicron population immunity for SARS-CoV-2 in the Household Influenza Vaccine Evaluation (HIVE) cohort
Yang, Y., Juntila-Raymond, C., Callear, A., Smith, M., Atkinson, R. K., Zhao, Y., Shah, R., Santos, J. J. S., Hensley, S., Monto, A. S., Martin, E. T.
10.64898/2026.03.10.26348071 — Posted: 2026-03-11
Assessing Attention Process Training Efficacy in Improving Brain Fog Symptoms in Individuals with Long Covid: A Study Protocol for a Randomized Controlled Trial
Magee, K., Roth, E., Cherney, L. R., Cohen-Zimerman, S.
10.64898/2026.03.10.26348047 — Posted: 2026-03-11
Constrained Diffusion as a Paradigm for Evolution
Lazarev, D., Sappington, A., Chau, G., Zhang, R., Berger, B.
10.64898/2026.03.10.710948 — Posted: 2026-03-11
Effectiveness of COVID-19 Vaccination Schedules Against Severe COVID-19 in Children Aged 6 Months to 4 Years in Brazil: A Population-Based Cohort Study (2023-2024)
Negretto Schrarstzhaupt, I., Diaz-Quijano, F. A.
10.64898/2026.03.03.26347530 — Posted: 2026-03-10
Assessment of accuracy of detection dog signaling behavior for the diagnosis of SARS-CoV-2 infection: A Canadian study
Mbutiwi, F. I. N., Otis, C., Schiller, I., LaChance, M., Martin, L., Jammal, A., Odita, A., Agbaje, N., Khatib, A., Dendukuri, N., Tamim, H., Troncy, E., Carabin, H.
10.64898/2026.03.04.26347154 — Posted: 2026-03-10
Anthracyclines inhibit -1 programmed ribosomal frameshifting and restrict HCoV-OC43 infection
Scheller, D., Islam, K., Lindgren, L., Arnberg, N., Johansson, J.
10.64898/2026.03.08.709729 — Posted: 2026-03-10
One and Done: A safe, adaptable single-cycle SARS-CoV-2 vaccine platform blocks XBB.1.5 infection and transmission
Schoen, J., Halwe, N. J., Britzke, T., Breithaupt, A., Ulrich, L., Kochmann, J., Corleis, B., Kipfer, E. T., Klimkait, T., Hoffmann, D., Otte, F., Beer, M., Hauser, D.
10.64898/2026.03.09.709481 — Posted: 2026-03-10
A Universal, AI-based Design Framework for Efficient Manufacturing of mRNA Therapeutics
Liao, K.-C., Maccari, G., Ciano, G., Huber, R., von der Haar, T., Tham, C.-Y., Ting Xun Ong, N., Florez de Sessions, P., Yih Saw, T., Wei Lim, T., Martin, C., Dickman, M., Kis, Z., Makatsoris, H., van Asbeck, A., Wan, Y., Medini, D.
10.64898/2026.03.09.710039 — Posted: 2026-03-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).